The CND classifies medical devices in three different levels – Category (first level), Group (second level) and Type (third level) – following an alphanumeric structure.

The CND classifies medical devices in three different levels – Category (first level), Group (second level) and Type (third level) – following an alphanumeric structure.
Read more about the New amendments brought by Regulation 2019/1966 on CMR Omnibus
The Cosmetic Products Notification Portal (CPNP) is an online system created by the European Commission. Read more about it.
Brexit officially enters into effect on January 31 2020. Find out what implications it has for your products and practices as Britain leaves the European Union.
Have your voice heard by the EU Commission. How to provide feedback on fragrance ingredients for cosmetics products on the EU market.
Read more about the opinion of the European Data Protection Supervisor holds for the implications of GDPR on clinical research conducted within the EU.
Advice and guidance from the Spanish regulatory experts on how to handle medical device labelling under Brexit. Assigning an EAR, notification, and more.
Understanding the safety assessment process and common concerns for nanomaterials within cosmetics products on the European market.
Throughout the many changes the EU Medical Device Regulations 2017/745 and 2017/746 will bring, one equally important is the introduction of a device traceability system based on Unique Device Identification, most commonly mentioned as UDI, within the healthcare supply chain. Read more about it here.
Cyclopentasiloxane (D5) and Cyclotetrasiloxane (D4), two of the most common silicones used in cosmetic products, were recently restricted for use in the European Union.